L-DOS47: Phase I/II ongoing

Helix began enrollment of the seventh dose level cohort of 1.04 µg/kg IV L-DOS47 in an open-label, Polish Phase I/II trial after a trial steering committee said the sixth dose level cohort in 3 patien...